Objective analysis of retinal function in HIV-positive children without retinitis using optical coherence tomography

Ocular Immunology and Inflammation

Volumn 15, Issue 4, 2007, Pages 319-323

  Moschos, Marilita M ^a,b   Mostrou, Glykeria ^a   Psimenidou, Eleni ^a   Spoulou, Vasiliki ^a   Theodoridou, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Human immunodeficiency virus infection; Optic nerve; Optical coherence tomography; Retinitis

Indexed keywords

BETA GLOBULIN; HEMOGLOBIN;

ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL COUNT; CHILD; CLINICAL ARTICLE; COLOR VISION; COLOR VISION TEST; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NERVE FIBER; OPHTHALMOSCOPY; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PROTEIN BLOOD LEVEL; RETINA; RETINA NERVE CELL; RETINITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLOR PERCEPTION; CYTOMEGALOVIRUS RETINITIS; FEMALE; FOLLOW-UP STUDIES; HIV; HIV ANTIBODIES; HIV SEROPOSITIVITY; HUMANS; MALE; OPTIC NERVE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 34548299512     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940701375154     Document Type: Article

References (22)

1. Schuman JS, Orellana J, Friedman AH, Teich SA. Acquired immunodeficiency syndrome (AIDS). Surv Ophthalmol. 1987;31:384-410.
2. Jabs DA, Van Natta ML, Kempen JH, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2002;133:48-61.
3. Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcomes of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30:231-233.
4. Plummer DJ, Sample PA, Arevalo JF, et al. Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol. 1996;122:542-549.
5. Quinceno JI, Capparelli E, Sadunn AA, et al. Visual dysfunction without retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;113:8-13.
6. Mueller AJ, Plummer DJ, Dua R, et al. Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol. 1997;124:158-167.
7. Latkany PA, Holopigian K, Lorenzo-Latkany M, Seiple M. Electroretinographic and psychophysical findings during early and late stages of human immunodeficiency virus infection and cytomegalovirus retinitis. Ophthalmology. 1997;104:445-453.
8. Freeman WR, Chen A, Henderly DA, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989;15:229-235.
9. El Beltagi TA, Bowd C, Boden C, et al. Retinal nerve fiber layer thickness measured with optical coherence tomography is related to visual function in glaucomatous eyes. Ophthalmology. 2003;110:2185-2191.
10. Jaffe GH, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004;137:156-159.
11. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
12. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;124:325-332.
13. Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103:1189-1198.
14. Koozekanani D, Roberts C, Katz SE Herderick EE. Intersession repeatability of macular thickness measurements using the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci. 2000;41:1486-1491.
15. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995;113:586-596.
16. Bowd C, Weinreb RN, Williams JM, Zangwill LM. The retinal nerve fiber layer thickness in ocular hypertensive, normal and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol. 2000;118:22-26.
17. Kozak I, Bartsch DU, Cheng L. Kosobucki B, Freeman WR. Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT. Am J Ophthalmol. 2005;139:295-301.
18. Liu X, Ling Y, Luo R, Ge J, Zheng X. Optical coherence tomography in measuring retinal nerve fiber layer thickness in normal subjects and patient with open-angle glaucoma. Clin Med J. 2001;114:524-529.
19. Varma R, Bazzaz S, Lai M. Optical tomography-measured retinal nerve fiber layer thickness in normal Latinos. Invest Ophthalmol Vis Sci. 2003;44:3369-3373.
20. Varma R, Skaf M, Barron E. Retinal nerve fiber layer thickness in normal eyes. Ophthalmology. 1998;103:2114-2119.
21. Mansour AM, Jampol LM, Logani S, Read J, Henderly D. Cotton wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion. Arch Ophthalmol. 1998;106:1074-1077.
22. Sample PA, Plummer DJ, Mueller AJ, et al. Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol. 1999;117:755-760.